Efficacy and safety of decitabine combined with low-dose cytarabine, aclarubicin, and granulocyte colony-stimulating factor compared with standard therapy in acute myeloid leukemia patients with TP53 mutation

Guardat en:
Dades bibliogràfiques
Publicat a:Chin Med J (Engl)
Autors principals: Chen, Si-Si, Sun, Qian, Cao, Lan, Wu, Wen-Zhong, Xie, Yue, Qiao, Chun, Li, Jian-Yong, Qian, Si-Xuan, Hong, Ming
Format: Artigo
Idioma:Inglês
Publicat: Lippincott Williams & Wilkins 2021
Matèries:
Clinical Observations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8213253/
https://ncbi.nlm.nih.gov/pubmed/33323826
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CM9.0000000000001316
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars